• SENSEX 81,028.02
    1,718.01 (+2.17%)
  • BANKNIFTY 59,086.00
    1,312.35 (+2.27%)
Back

Corporate News

Nectar Lifesciences schedules board meeting to review quarterly financial results
06-Nov-2026, 01:17

Nectar Lifesciences Ltd. will hold a board meeting on November 14, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026, according to a regulatory filing with the National Stock Exchange of India Limited and BSE Limited.